PrymaLab Analytical
Public test results
Results that clients chose to publish, plus PrymaLab's own lot certificates of analysis, newest first. Each line links to the full report. For client samples we list the brand or source exactly as the client declared it and have no relationship with any of the companies named; a listing is not an endorsement. Lines marked Lot COA are PrymaLab production lots tested in our own laboratory.
109 published results
| Test | Compound tested | Declared as | Brand / source | Result | Verdict | Published |
|---|---|---|---|---|---|---|
| PL-26-00120 Lot COA |
Vilon 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-120 |
PrymaLab | 99.54% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00119 Lot COA |
Vesugen 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-119 |
PrymaLab | 99.55% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00118 Lot COA |
Triptorelin (GnRH) 2 mg In-house lot release testing |
2 mg/vial Lot PL-2609-118 |
PrymaLab | 99.30% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00117 Lot COA |
Tirzepatide 100 mg In-house lot release testing |
100 mg/vial Lot PL-2609-117 |
PrymaLab | 99.29% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00116 Lot COA |
Tirzepatide 80 mg In-house lot release testing |
80 mg/vial Lot PL-2609-116 |
PrymaLab | 99.21% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00115 Lot COA |
Tirzepatide 60 mg In-house lot release testing |
60 mg/vial Lot PL-2609-115 |
PrymaLab | 99.27% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00114 Lot COA |
Tirzepatide 50 mg In-house lot release testing |
50 mg/vial Lot PL-2609-114 |
PrymaLab | 99.24% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00113 Lot COA |
Tirzepatide 40 mg In-house lot release testing |
40 mg/vial Lot PL-2609-113 |
PrymaLab | 99.32% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00112 Lot COA |
Tirzepatide 30 mg In-house lot release testing |
30 mg/vial Lot PL-2609-112 |
PrymaLab | 99.26% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00111 Lot COA |
Tirzepatide 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-111 |
PrymaLab | 99.23% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00110 Lot COA |
Tirzepatide 15 mg In-house lot release testing |
15 mg/vial Lot PL-2609-110 |
PrymaLab | 99.30% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00109 Lot COA |
Tirzepatide 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-109 |
PrymaLab | 99.25% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00108 Lot COA |
Tirzepatide 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-108 |
PrymaLab | 99.28% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00107 Lot COA |
Thymosin Alpha-1 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-107 |
PrymaLab | 99.35% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00106 Lot COA |
Thymosin Alpha-1 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-106 |
PrymaLab | 99.82% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00104 Lot COA |
Testagen 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-104 |
PrymaLab | 99.53% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00102 Lot COA |
TB-500 (Thymosin ฮฒ4) 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-102 |
PrymaLab | 99.53% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00101 Lot COA |
TB-500 (Thymosin ฮฒ4) 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-101 |
PrymaLab | 99.74% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00098 Lot COA |
Sermorelin 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-098 |
PrymaLab | 99.63% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00097 Lot COA |
Sermorelin 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-097 |
PrymaLab | 99.54% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00096 Lot COA |
Semax 11 mg In-house lot release testing |
11 mg/vial Lot PL-2609-096 |
PrymaLab | 99.76% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00095 Lot COA |
Semax 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-095 |
PrymaLab | 99.57% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00094 Lot COA |
Semaglutide 30 mg In-house lot release testing |
30 mg/vial Lot PL-2609-094 |
PrymaLab | 99.35% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00093 Lot COA |
Semaglutide 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-093 |
PrymaLab | 99.27% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00092 Lot COA |
Semaglutide 15 mg In-house lot release testing |
15 mg/vial Lot PL-2609-092 |
PrymaLab | 99.31% purity | Released: PASS | Oct 3, 2026 |
A verdict compares what we measured with what the label claimed: within 10% is "matches label". Client reports describe the sample received and say nothing about where it came from. "Released: PASS" on a lot COA means the PrymaLab lot met every specification on its certificate. Want your own result here? Order a test and tick "publish".
